Abstract
Pharmacoeconomic evaluation of ceftazidime + avibactam administration in the treatment of nosocomial pneumonia caused by carbapenem-resistant Enterobacteriacea and complicated by bacteremia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have